EdgarLookup

US BANCORP \DE\ — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that US BANCORP \DE\ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
26.4%
Profit Margin
Net income ÷ revenue
1.1%
Return on Assets
Net income ÷ assets
9.61x
Debt-to-Equity
Total liabilities ÷ equity
+4.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $28.66B Feb 23, 2026
FY2025 Dec 31, 2024 $27.46B Feb 23, 2026
FY2025 Dec 31, 2023 $28.14B Feb 23, 2026
FY2024 Dec 31, 2022 $24.30B Feb 21, 2025
FY2018 Dec 31, 2018 $22.64B Feb 22, 2019
FY2018 Dec 31, 2017 $21.90B Feb 22, 2019
FY2017 Dec 31, 2016 $21.31B Feb 22, 2018
FY2016 Dec 31, 2015 $20.31B Feb 23, 2017
FY2015 Dec 31, 2014 $20.16B Feb 25, 2016
FY2014 Dec 31, 2013 $19.60B Feb 27, 2015

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.57B Feb 23, 2026
FY2025 Dec 31, 2024 $6.30B Feb 23, 2026
FY2025 Dec 31, 2023 $5.43B Feb 23, 2026
FY2024 Dec 31, 2022 $5.83B Feb 21, 2025
FY2023 Dec 31, 2021 $7.96B Feb 20, 2024
FY2022 Dec 31, 2020 $4.96B Feb 27, 2023
FY2021 Dec 31, 2019 $6.91B Feb 22, 2022
FY2020 Dec 31, 2018 $7.10B Feb 23, 2021
FY2019 Dec 31, 2017 $6.22B Feb 20, 2020
FY2018 Dec 31, 2016 $5.89B Feb 22, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.97B Feb 23, 2026
FY2025 Dec 31, 2024 $11.35B Feb 23, 2026
FY2025 Dec 31, 2023 $8.39B Feb 23, 2026
FY2024 Dec 31, 2022 $21.12B Feb 21, 2025
FY2023 Dec 31, 2021 $9.87B Feb 20, 2024
FY2022 Dec 31, 2020 $3.72B Feb 27, 2023
FY2021 Dec 31, 2019 $4.89B Feb 22, 2022
FY2020 Dec 31, 2018 $10.56B Feb 23, 2021
FY2019 Dec 31, 2017 $6.47B Feb 20, 2020
FY2018 Dec 31, 2016 $5.34B Feb 22, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $692.35B Feb 23, 2026
FY2025 Dec 31, 2024 $678.32B Feb 23, 2026
FY2024 Dec 31, 2023 $663.49B Feb 21, 2025
FY2023 Dec 31, 2022 $674.81B Feb 20, 2024
FY2022 Dec 31, 2021 $573.28B Feb 27, 2023
FY2021 Dec 31, 2020 $553.91B Feb 22, 2022
FY2020 Dec 31, 2019 $495.43B Feb 23, 2021
FY2019 Dec 31, 2018 $467.37B Feb 20, 2020
FY2018 Dec 31, 2017 $462.04B Feb 22, 2019
FY2017 Dec 31, 2016 $445.96B Feb 22, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $626.69B Feb 23, 2026
FY2025 Dec 31, 2024 $619.28B Feb 23, 2026
FY2024 Dec 31, 2023 $607.72B Feb 21, 2025
FY2023 Dec 31, 2022 $623.57B Feb 20, 2024
FY2022 Dec 31, 2021 $517.90B Feb 27, 2023
FY2021 Dec 31, 2020 $500.18B Feb 22, 2022
FY2020 Dec 31, 2019 $442.94B Feb 23, 2021
FY2019 Dec 31, 2018 $415.72B Feb 20, 2020
FY2018 Dec 31, 2017 $412.37B Feb 22, 2019
FY2017 Dec 31, 2016 $398.03B Feb 22, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $65.19B Feb 23, 2026
FY2025 Dec 31, 2024 $58.58B Feb 23, 2026
FY2024 Dec 31, 2023 $55.31B Feb 21, 2025
FY2023 Dec 31, 2022 $50.77B Feb 20, 2024
FY2022 Dec 31, 2021 $54.92B Feb 27, 2023
FY2021 Dec 31, 2020 $53.10B Feb 22, 2022
FY2020 Dec 31, 2019 $51.85B Feb 23, 2021
FY2019 Dec 31, 2018 $51.03B Feb 20, 2020
FY2018 Dec 31, 2017 $49.04B Feb 22, 2019
FY2017 Dec 31, 2016 $47.30B Feb 22, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.64B Feb 23, 2026
FY2025 Dec 31, 2024 $12.54B Feb 23, 2026
FY2025 Dec 31, 2023 $12.49B Feb 23, 2026
FY2025 Dec 31, 2022 $12.37B Feb 23, 2026
FY2024 Dec 31, 2021 $10.26B Feb 21, 2025
FY2023 Dec 31, 2020 $9.92B Feb 20, 2024
FY2022 Dec 31, 2019 $9.66B Feb 27, 2023
FY2021 Dec 31, 2018 $9.37B Feb 22, 2022
FY2020 Dec 31, 2017 $9.43B Feb 23, 2021
FY2019 Dec 31, 2016 $9.34B Feb 20, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $80.91B Feb 23, 2026
FY2025 Dec 31, 2024 $76.86B Feb 23, 2026
FY2024 Dec 31, 2023 $74.03B Feb 21, 2025
FY2023 Dec 31, 2022 $71.90B Feb 20, 2024
FY2022 Dec 31, 2021 $69.20B Feb 27, 2023
FY2021 Dec 31, 2020 $64.19B Feb 22, 2022
FY2020 Dec 31, 2019 $63.19B Feb 23, 2021
FY2019 Dec 31, 2018 $59.07B Feb 20, 2020
FY2018 Dec 31, 2017 $54.14B Feb 22, 2019
FY2017 Dec 31, 2016 $50.15B Feb 22, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $8.25B Feb 22, 2013
FY2011 Dec 31, 2011 $13.96B Feb 23, 2012
FY2010 Dec 31, 2010 $14.49B Feb 28, 2011
FY2009 Dec 31, 2009 $6.21B Feb 26, 2010
FY2009 Dec 31, 2008 $6.86B Feb 26, 2010
FY2009 Dec 31, 2007 $8.88B Feb 26, 2010
FY2009 Dec 31, 2006 $8.64B Feb 26, 2010

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $39.83B Feb 27, 2023
FY2022 Dec 31, 2021 $32.13B Feb 27, 2023
FY2021 Dec 31, 2020 $41.30B Feb 22, 2022
FY2020 Dec 31, 2019 $40.17B Feb 23, 2021
FY2019 Dec 31, 2018 $41.34B Feb 20, 2020
FY2018 Dec 31, 2017 $32.26B Feb 22, 2019
FY2017 Dec 31, 2016 $33.32B Feb 22, 2018
FY2016 Dec 31, 2015 $32.08B Feb 23, 2017
FY2015 Dec 31, 2014 $32.26B Feb 25, 2016
FY2014 Dec 31, 2013 $20.05B Feb 27, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 4 Feb 23, 2026
FY2025 Dec 31, 2024 3 Feb 23, 2026
FY2025 Dec 31, 2023 3 Feb 23, 2026
FY2024 Dec 31, 2022 3 Feb 21, 2025
FY2023 Dec 31, 2021 5 Feb 20, 2024
FY2022 Dec 31, 2020 3 Feb 27, 2023
FY2021 Dec 31, 2019 4 Feb 22, 2022
FY2020 Dec 31, 2018 4 Feb 23, 2021
FY2019 Dec 31, 2017 3 Feb 20, 2020
FY2018 Dec 31, 2016 3 Feb 22, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 4 Feb 23, 2026
FY2025 Dec 31, 2024 3 Feb 23, 2026
FY2025 Dec 31, 2023 3 Feb 23, 2026
FY2024 Dec 31, 2022 3 Feb 21, 2025
FY2023 Dec 31, 2021 5 Feb 20, 2024
FY2022 Dec 31, 2020 3 Feb 27, 2023
FY2021 Dec 31, 2019 4 Feb 22, 2022
FY2020 Dec 31, 2018 4 Feb 23, 2021
FY2019 Dec 31, 2017 3 Feb 20, 2020
FY2018 Dec 31, 2016 3 Feb 22, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1.60B Feb 23, 2026
FY2024 Dec 31, 2024 1.60B Feb 21, 2025
FY2023 Dec 31, 2023 1.60B Feb 20, 2024
FY2023 Dec 31, 2022 1.50B Feb 20, 2024
FY2022 Dec 31, 2021 1.50B Feb 27, 2023
FY2021 Dec 31, 2020 1.50B Feb 22, 2022
FY2020 Dec 31, 2019 1.50B Feb 23, 2021
FY2019 Dec 31, 2018 1.60B Feb 20, 2020
FY2018 Dec 31, 2017 1.70B Feb 22, 2019
FY2017 Dec 31, 2016 1.70B Feb 22, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.17B Feb 23, 2026
FY2025 Dec 31, 2024 $3.09B Feb 23, 2026
FY2025 Dec 31, 2023 $2.97B Feb 23, 2026
FY2024 Dec 31, 2022 $2.78B Feb 21, 2025
FY2023 Dec 31, 2021 $2.58B Feb 20, 2024
FY2022 Dec 31, 2020 $2.55B Feb 27, 2023
FY2021 Dec 31, 2019 $2.44B Feb 22, 2022
FY2020 Dec 31, 2018 $2.09B Feb 23, 2021
FY2019 Dec 31, 2017 $1.93B Feb 20, 2020
FY2018 Dec 31, 2016 $1.81B Feb 22, 2019